Bio-waiver of Sapro­pterin dihydrochloride powder for oral solution [Dissolution / BCS / IVIVC]

posted by AB661 – India, 2019-11-22 17:49 (332 d 07:01 ago) – Posting: # 20861
Views: 2,172

Dear All,

We are developing Sapropterin dihydrochloride powder for oral solution,

We are going to file BCS based Bio-waiver approach using solubility, dissolution & composition similarity.

But for permeability study there is no literature support for human absolute bioavailability study or in-vitro permeability study of Sapropterin dihydrochloride. Whether USFDA accept our proposal without permeability study data ?

With regards

Edit: Category changed; see also this post #1[Helmut]

Complete thread:

 Admin contact
21,162 posts in 4,410 threads, 1,476 registered users;
online 12 (0 registered, 12 guests [including 6 identified bots]).
Forum time: Tuesday 01:51 CEST (Europe/Vienna)

In theory, there is no difference between theory and practice.
But, in practice, there is.    Jan L.A. van de Snepscheut

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz